Showing pharmacokinetics for Resveratrol 3-sulfate metabolite after consumption of Resveratrol in humans Metabolism
Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., Brenner D.E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16:1246-52 PubMed (17548692)
Urine analysed without enzymatic deconjugation
Show related metabolites from the same publication
| Cumulative Excretion in Urine (% of dose) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number | Dose | Multiple Dose Duration | Time (hours) |
Polyphenol Source Name as described in publication |
|||||
| 0 | 2 | 4 | 8 | 12 | 24 | ||||
| 1 | 0.5 g | Single Dose | 0 | 3.8 | 7.6 | 10.4 | 11.4 | 11.5 |
resveratrol
|